Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic - Report - MDSpire

Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic

  • By

  • Robert Dotzauer

  • Katharina Böhm

  • Maximilian Peter Brandt

  • Peter Sparwasser

  • Maximilian Haack

  • Sebastian. Karl Frees

  • Mohamed Mostafa Kamal

  • René Mager

  • Wolfgang Jäger

  • Thomas Höfner

  • Igor Tsaur

  • Axel Haferkamp

  • Hendrik Borgmann

  • July 4, 2020

  • 0 min

Share

Clinical Report: Impact of COVID-19 on Urological Surgical and Oncological Practices

Overview

A global survey of 235 urologists from 44 countries revealed that 93% changed their clinical practice during the initial COVID-19 pandemic phase. Surgical activity was widely down-escalated, with prioritization of urgent oncological procedures and suspension of elective surgeries.

Background

The COVID-19 pandemic, declared by WHO in March 2020, has strained healthcare systems worldwide, necessitating resource reallocation and surgical prioritization. Urological surgeries, especially oncological procedures, face ethical challenges due to potential delays increasing cancer progression risks. This study aimed to quantify global changes in urological surgical and oncological management during the pandemic's early phase. Understanding these changes can guide clinicians in balancing cancer treatment urgency with pandemic constraints.

Data Highlights

ParameterValue
Survey respondents235 urologists
Countries represented44
High-risk COVID-19 countries63%
Public hospital respondents76%
Change in clinical practice due to COVID-1993%
Down-escalation stages of surgeryStage 1: 44%, Stage 2: 23%, Stage 3: 20%, Stage 4: 13%

Key Findings

  • 93% of urologists reported changes in clinical practice due to COVID-19.
  • 44% were in stage 1 down-escalation (first cancellations), 23% in stage 2, 20% in stage 3, and 13% in stage 4 (emergency cases only).
  • Prioritization favored urgent oncological surgeries over elective and non-oncological procedures.
  • Public hospitals represented the majority (76%) of respondents, indicating widespread impact across healthcare settings.
  • High-risk COVID-19 countries accounted for 63% of respondents, reflecting greater practice modifications in these areas.

Clinical Implications

Clinicians should anticipate and implement stepwise surgical down-escalation strategies during pandemics, prioritizing urgent oncological cases to minimize adverse cancer outcomes. Awareness of local COVID-19 risk status can guide resource allocation and treatment decisions. Multidisciplinary coordination is essential to balance cancer progression risks against pandemic-related healthcare constraints.

Conclusion

The COVID-19 pandemic has led to significant global modifications in urological surgical and oncological practices, emphasizing prioritization and resource conservation. These findings provide a benchmark for clinicians managing urological patients during ongoing and future healthcare crises.

References

  1. WHO 2020 -- COVID-19 Pandemic Declaration and Global Impact
  2. SurveyMonkey 2020 -- Online Survey on Urological Practice Changes
  3. CHERRIES 2011 -- Checklist for Reporting Internet E-Surveys
  4. STROBE 2007 -- Strengthening the Reporting of Observational Studies in Epidemiology

Original Source(s)

Related Content